[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/pages/docs/Technology/index.md) >> Individual ID:PBN__Technology_7998 

# __Clinical trial management systems__

## Risks linked to this technology

* [Absence of approved therapy for covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6585.md)
* [Delayed availability of treatments due to extensive scientific checks and clinical trials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6688.md)
* [Inaccurate identification of potential drugs for clinical trials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7126.md)
* [Long timeline for commercial release of vaccines](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11050.md)
* [Prediction of unknown side effects leading to unforeseen health risks](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12078.md)
* [Use of experimental and unapproved drugs for covid-19 treatment](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14464.md)

## This Technology belongs to this TechGroup

* [Healthcare](https://github.com/mm80843/T3.5/blob/pages/TechGroup/PBN__TechGroup_2.md)

## This Technology belongs to this TechSubgroup

* [Vaccination development and distribution](https://github.com/mm80843/T3.5/blob/pages/TechSubgroup/PBN__TechSubgroup_66.md)

## This technology is mentioned by

* [Chamola_comprehensive_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_441.md)
* [Cirrincione_covid-19_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_430.md)
* [Shorfuzzaman_towards_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_511.md)
* [Wang_construction_2022](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_569.md)
* [Willems_how_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_521.md)

